Antioxidant status of serum, muscle, intestine and hepatopancreas for fish fed graded levels of biotin

Feng, Lin; Zhao, Sheng‐Yin; Chen, Gangfu; Jiang, Wei‐Dan; Liu, Yang; Jiang, Jun; Hu, Kai; Li, Shuhong; Zhou, Xiao‐Qiu

doi:10.1007/s10695-013-9861-z

Cited by 30 publications

(28 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, we surveyed a few serum antioxidant-related parameters, including SOD, CAT, T-AOC, GSH-Px and MDA, to confirm whether COS can improve the antioxidant status of sows. Interestingly, we observed a decreased serum MDA content, which indicates that lipid peroxidation could be reduced by COS (Feng et al 2014). CAT is implicated as an essential defence enzyme against the potential toxicity of hydroxyl radicals, and T-AOC reflects the total antioxidant capacity of the organism (Fang et al 2016;.…”

Section: Discussionmentioning

confidence: 71%

Maternal chitosan oligosaccharide supplementation during late gestation and lactation affects offspring growth

Wan

2018

Italian Journal of Animal Science

View full text Add to dashboard Cite

Chitosan oligosaccharide (COS), a natural compound derived from chitin, has growth promotion property. However, the nature of the relationship between maternal COS supplementation and offspring growth is not yet understood. Therefore, we intended to determine the effects of maternal COS supplementation in late gestation and lactation on the offspring growth performance. Twenty-four pregnant Yorkshire sows were distributed into two equal groups (n ¼ 12) and fed either with a basal diet (control group) or a basal diet containing 100 mg/kg COS, from gestation day 85 until lactation day 21. Serum samples were collected from six sows of average body weight, from each group on farrowing day (lactation day 1) and lactation day 21, whereas colostrum and milk samples were respectively obtained on lactation days 1 and 21. We found that maternal COS supplementation significantly increased (p < .05) the average piglet weaning weight per litter. Supplementation of COS in the sow diet elevated (p < .05) the serum interleukin-10, immunoglobulin A (IgA) and IgM concentrations, as well as total antioxidant capacity. Moreover, higher (p < .05) colostrum IgM and milk lactose contents were simultaneously observed in COS-treated sows compared to the control sows. In summary, COS supplementation during late gestation and lactation can boost antioxidant capacity and humoural immunity of sows, and contributes to improving colostrum and milk quality, ultimately, enhancing the offspring growth performance. ARTICLE HISTORY

show abstract

Section: Discussionmentioning

confidence: 71%

Maternal chitosan oligosaccharide supplementation during late gestation and lactation affects offspring growth

Wan

2018

Italian Journal of Animal Science

View full text Add to dashboard Cite

show abstract

“…Excessive amounts of ROS can lead to lipid peroxidation in organisms. Malondialdehyde (MDA) is the most familiar breakdown product of lipid peroxidation, and its level is frequently used as a direct marker of lipid oxidative damage caused by ROS ( Feng et al., 2014 ). The results of MDA in this study indicated that spermine significantly reduced MDA content in the jejunum, thereby suggesting that spermine could depress lipid peroxidation in weaning rats.…”

Section: Discussionmentioning

confidence: 99%

Effects of spermine supplementation on the morphology, digestive enzyme activities, and antioxidant capacity of intestine in weaning rats

et al. 2016

View full text Add to dashboard Cite

The main objective of this study was to investigate the effects of different doses of spermine and its extended supplementation on the morphology, digestive enzyme activities, and intestinal antioxidant capacity in weaning rats. Nineteen-day-old male rats received intragastric spermine at doses of 0.2 and 0.4 μmol/g BW for 3 or 7 d, whereas control rats received similar doses of saline. The results are as follows: 1) In the jejunum, the seven-day supplementation with both doses of spermine significantly increased crypt depth (P < 0.05) compared with the control group; the supplementation extension of the high spermine dose increased villus height and crypt depth (P < 0.05); in the ileum, the low spermine dose significantly increased villus height and crypt depth compared with the control group for 7 days (P < 0.05). 2) The 3-day supplementation with high spermine dose increased alkaline phosphatase activity in the jejunum (P < 0.05). 3) In the jejunum, the anti-hydroxyl radical (AHR), total superoxide dismutase (T-SOD), catalase (CAT), and total antioxidant capacity (T-AOC) activities were increased (P < 0.05); however, the malondialdehyde (MDA) content was reduced (P < 0.05) in groups supplemented with the high spermine dose relative to those in the control groups after 3 and 7 d; moreover, the anti-superoxide anion (ASA) and glutathione (GSH) contents increased with the high spermine dose that lasted for 3 days (P < 0.05). Furthermore, the T-SOD and CAT activities (after 3 and 7 d), ASA (after 3 d), and AHR (after 7 d) increased with the high spermine dose compared with those of the low spermine dose (P < 0.05). Extending the supplementation duration (7 d) of the high spermine dose decreased the MDA content and ASA and T-AOC activities (P < 0.05). These results suggested that spermine supplementation can modulate gut development and enhance the antioxidant status of the jejunum in weaning rats, and a dosage of 0.4 μmol spermine/g BW had better effects than the dosage of 0.2 μmol spermine/g BW on accelerating gut development and increasing antioxidant capacity.

show abstract

“…TTFD is a derivative of the B-vitamin thiamine and as such it is a sulfur doi: 10.7243/2054-992X-3-3 containing compound with antioxidant properties [38,39]. Biotin is another B-vitamin which contains sulfur and from animal studies it can also serve as an antioxidant as well [40]. Blood levels of biotin in autism are typically low relative to controls [2].…”

Section: Sulfur Containing Antioxidants As Therapeutics For Autismmentioning

confidence: 99%

Antioxidant sulfur compounds: potential therapies for autism?

Bittker¹

2016

J Autism

View full text Add to dashboard Cite

Many of those with autism have biochemistry that is characterized by high levels of oxidative stress and low levels of sulfur antioxidants. Of the small set of compounds which have been shown to have some efficacy in double-blind trials in treating some aspects of autism, four are sulfur containing compounds with antioxidant properties. Specifically these four have been found to be efficacious with statistical significance in double-blind trials in autism: n-acetylcysteine, sulforaphane, l-carnitine, and a multivitamin containing methyl-sufonyl-methane and n-acetylcysteine. Each of these compounds has antioxidant properties, and there are other sulfur containing compounds with antioxidant properties which case studies suggest may have some efficacy in autism as well. The over-representation of sulfur containing antioxidants in the set of compounds that have been found to be therapeutic for autism as well as the indications of therapeutic potential of others, and the low levels of sulfur compounds and high oxidative stress that are often seen in autism biochemistry suggest that sulfur deficits are often fundamental to autism etiology, and sulfur containing antioxidants are worthy of additional study as a class of therapeutics for autism.

show abstract

Antioxidant status of serum, muscle, intestine and hepatopancreas for fish fed graded levels of biotin

Cited by 30 publications

References 63 publications

Maternal chitosan oligosaccharide supplementation during late gestation and lactation affects offspring growth

Maternal chitosan oligosaccharide supplementation during late gestation and lactation affects offspring growth

Effects of spermine supplementation on the morphology, digestive enzyme activities, and antioxidant capacity of intestine in weaning rats

Antioxidant sulfur compounds: potential therapies for autism?

Contact Info

Product

Resources

About